Le Lézard
Classified in: Environment, Health, Science and technology
Subject: Corporate Social Responsibility

Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the release of its second annual ESG report, outlining the Company's long-term commitment to the betterment of society, focusing on patients, our employees, the community, the environment, and shareholders. The report builds on Arena's inaugural report and highlights specific data and examples of the Company's work to advance ESG priorities.

"At Arena we believe in operating responsibly by aligning our business priorities with our corporate aspiration to Care More. Act Differently," said Amit Munshi, Director, President and CEO of Arena Pharmaceuticals. "Our focus on ESG is a journey of continuous improvement as we assess our approach, monitor our impact and build toward the future, incorporating this pattern of thinking into every decision that we make as a company. This ESG focus allows us to build a sustainable company, even in the face of huge challenges such as the COVID pandemic."

In line with Arena's focus, this year's report outlines our evolving approach to managing environmental, social, and governance risks and capturing associated opportunities.

View the full 2021 Arena ESG Report on the Arena Investor page: https://invest.arenapharm.com/.

About Arena Pharmaceuticals

ARENA Pharmaceuticals is a team with a singular purpose ? deliver important medicines to patients.

In a rapidly changing global market, we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to get medicines to patients, and relentlessly execute until it's done.

We are developing a richly diversified portfolio of therapeutic candidates targeting gastroenterology, dermatology and cardiology. Our pipeline includes four investigational medicines in eight indications and eleven ongoing or planned clinical trials. To fuel our growth, we are unlocking the value of our historical GPCR research with a sustainable discovery engine for broad portfolio expansion.

ARENA - Care More. Act Differently.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's dedication, commitment, plans, purpose, work, understanding, ideas, execution, portfolio development and expansion, growth, and sustainable discovery engine. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

These press releases may also interest you

at 14:00
The Human Animal Bond Research Institute (HABRI) and Zoetis announced today the results of a survey of 16,000 dog and cat owners and 1,200 veterinarians across eight countries and four continents. The research shows that the human-animal bond is...

at 06:30
As part of Georgia Governor Brian Kemp's initiative to increase the availability and access to efficient COVID-19 PCR testing, Viral Solutions has been chosen by the Georgia Department of Public Health (GaDPH) to spearhead an effort to rapidly open...

15 jan 2022
Core One Labs Inc. , , ("Core One" or the "Company") is pleased to announce, as a follow up to the press release dated January 10, that Dr. Robert E.W. Hancock, the Company's Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies...

15 jan 2022
Vial announces that in conjunction with the 2022 Winter Clinical Dermatology conference it will host an Advisory Board with leading research sites to discuss the challenges in clinical research with a focus on improving speed and quality of trials in...

15 jan 2022
WHAT: HairClub, with our Miami Heat partner, is donating a once-in-a-lifetime all-inclusive suite night and 200 tickets to a deserving selection of community-driven centers and organizations around South Florida. WHO/WHEN: As part of HairClub's...

15 jan 2022
In the news release, Color Street Foundation Pledges $1M to March of Dimes to Improve Maternal and Infant Health, issued 11-Jan-2022 by Color Street over PR Newswire, we are advised by the company that the "Color Street Foundation" hyperlink in...

News published on 19 april 2021 at 16:10 and distributed by: